Antimicrobial Strategy Manchester

A multidisciplinary task force equipped to be responsive to trends in local and global infection.



Infectious disease is a major cause of human deaths, yet the efficacy of antimicrobial drugs continues to decline.


The currently escalating global coronavirus (COVID-19) pandemic has revealed a critical need to continually resource the development of antimicrobial strategy, a multidisciplinary challenge that can be tackled at pace in Manchester.

With University of Manchester Research Infrastructure funding, we are assembling a community of clinical, academic and industry partners focused on antimicrobial strategy.

Our network seeks to convene experts and skillsets across every clinical, diagnostic, academic, biotechnological and industrial avenue of research and clinical practice to address this critical global challenge.



Join the network

Join our network to receive updates including information on seminars, pump-prime funding and the network launch event in 2020.

By signing up, you agree to be contacted so we can acquire professional profile information to be published on this website.



Our goals

We aim to identify immediate priorities for local COVID-19 research and clinical practice, and assemble a rapid response taskforce to take the work forward.


We also want to work towards the strategic goals that major UK and international funders are united in addressing through UKRI’s priority of tackling antimicrobial resistance.

Strategic goals

  • Refreshing the pipeline for antimicrobials.
  • Developing new non-drug based treatments.
  • Developing new animal and human vaccines.
  • Revolutionise diagnostic capability.

These are in line with the Department of Health’s 5-year action plan and 20-year vision for antimicrobial strategy, focusing on infection control, stewardship, and drug and vaccine discovery. This is supported by funding through UKRI (£44 million) and NIHR (£56 million).



Our approach

We will address the above goals through:

  • Institution-scale infrastructure addressing practice, policy, new drugs and the environment.
  • Pump-priming funding for multidisciplinary collaborations addressing critical need, particularly academic-clinician-industrial partnerships.
  • A heat map of infection hotspots across Manchester University NHS Foundation Trust for an epidemiological view of local concerns, helping define and quantify antimicrobial usage by clinical discipline.
  • An Academy of Medical Microbiology to deliver training to UK and international medical microbiologists to combat the global spread of infectious diseases and AMR.
  • Heightened prominence for translational infectious disease research at The University of Manchester.

You can get involved by joining us. Complete the online form to sign up to the network.




Get in touch for more information about Antimicrobial Strategy Manchester.


Professor Elaine Bignell (Academic Lead)
Bethany McCann (Project Manager)


Follow us on Twitter: @AMS_UoM